Ringpu Bio-Technology to co-invest in new pet industry fund

Ringpu Bio-Technology is set to co-invest 154 million yuan into Tianjin BaoRui Equity Investment Partnership (Limited Partnership), a newly established entity with a total subscribed capital of 406 million yuan. This investment, representing 37.9310% of the partnership, aims to expand Ringpu Bio-Technology’s presence in the pet industry value chain, covering pet medical services, food, and other related services.

The partnership, which has a six-year operating period with a one-year investment phase and a five-year exit phase, was approved by the company's board of directors and supervisory board on October 13, 2025. The investment committee, comprising two members from Mingzhi Hexin, one from Xinxing Fund, and one from Ringpu Bio-Technology, will make investment decisions based on unanimous consent.

Other partners in the fund include Tianjin Port Free Trade Zone Xinxing Industry Development Fund Partnership, Tianjin Lingang Equity Investment Fund Management Co., Ltd., and Mingzhi Hexin (Tianjin) Equity Investment Fund Management Co., Ltd. The investment is expected to enhance Ringpu Bio-Technology's overall competitiveness by leveraging the expertise and resources of professional institutions, though it carries risks associated with long investment cycles and potential market fluctuations.